Back to search
FDAFDA · Food and drugs·Recall number D-0521-2022

Mimvey (estradiol and norethindrone acetate tablets USP), 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pharmaceuticals USA Inc. North Wales, PA 19454, NDC 0093-5455-28

Published February 9, 2022 · Recall initiated: January 7, 2022

Summary

FDA records drug Class III recall D-0521-2022, published February 9, 2022 and initiated January 7, 2022. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 218174 cartons; Lot: Lot#: 100018611, Exp 03/2022; 100019834, Exp 06/2022; 100022226, Exp 09/2022; 100024574, Exp 01/2023. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Mislabeling

What to do

Voluntary: Firm initiated · Letter

Get an email if MIMVEY has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MIMVEY
Manufacturer
Teva Pharmaceuticals USA
Distributor
USA Nationwide
Lot
Lot#: 100018611, Exp 03/2022; 100019834, Exp 06/2022; 100022226, Exp 09/2022; 100024574, Exp 01/2023
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Mimvey (estradiol and norethindrone acetate tablets USP), 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pharmaceuticals USA Inc. North Wales, PA 19454, NDC 0093-5455-28 recalled?

Yes. FDA published recall D-0521-2022 on February 9, 2022. Reported hazard: Mislabeling

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MIMVEY.